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Abstract: 16 
The helicase-primase interaction is an essential event in DNA replication and is mediated by 17 
the highly variable C-terminal domain of primase (DnaG) and N-terminal domain of helicase 18 
(DnaB). To understand the functional conservation despite the low sequence homology of the 19 
DnaB-binding domains of DnaGs of eubacteria, we determined the crystal structure of the 20 
helicase-binding domain of DnaG from M. tuberculosis (MtDnaG-CTD), and did so to a 21 
resolution of 1.58 Å. We observed the overall structure of MtDnaG-CTD to consist of two 22 
subdomains, the N-terminal globular region (GR) and the C-terminal helical hairpin region 23 
(HHR), connected by a small loop. Despite differences in some of its helices, the globular 24 
region was found to have broadly similar arrangements across the species, whereas the helical 25 
hairpins showed different orientations. To gain insight into the crucial helicase-primase 26 
interaction in M. tuberculosis, a complex was modeled using the MtDnaG-CTD and MtDnaB-27 
NTD crystal structures. Two nonconserved hydrophobic residues (Ile605 and Phe615) of 28 
MtDnaG were identified as potential key residues interacting with MtDnaB. Biosensor 29 
binding studies showed a significant decrease in the binding affinity of MtDnaB-NTD with 30 
the Ile605Ala mutant of MtDnaG-CTD compared to native MtDnaG-CTD. The loop, 31 
connecting the two helices of the HHR, was concluded to be largely responsible for the 32 
stability of the DnaB-DnaG complex. Also, MtDnaB-NTD showed micromolar affinity with 33 
DnaG-CTDs from E. coli and H. pylori and unstable binding with DnaG-CTD from V. 34 
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cholerae. The interacting domains of both DnaG and DnaB demonstrate the species-specific 35 
evolution of the replication initiation system. 36 
37 
Introduction: 38 
DNA replication is a fundamental process in all domains of life and requires a large 39 
molecular machine coordinating the action of dozens of discrete factors to ensure accurate 40 
genome inheritance (1). The interaction between the bacterial replicative ring helicase 41 
(DnaB) and the primase (DnaG) is essential for the formation of the functional primosome at 42 
oriC to initiate the DNA replication (2, 3). DnaB helicase unwinds duplex DNA into single-43 
stranded DNA (ssDNA), with this unwinding fueled by the hydrolysis of nucleoside 44 
triphosphate at the replication fork (4-6); and DnaG primase uses the newly formed ssDNA 45 
as a template for the de novo synthesis of RNA primers to initiate the DNA replication (7). 46 
The interaction between DnaB and DnaG mutually stimulates both of their activities (8). 47 
DnaG increases both the NTPase and helicase activities of DnaB (9) while DnaB increases 48 
and modulates the synthesis of RNA primers by DnaG (7, 10, 11). The DnaG primase 49 
consists of three domains with distinct activities; an N-terminal zinc-binding domain, a 50 
central RNA polymerase domain and a C-terminal helicase-binding domain. The C-terminal 51 
domain of DnaG (DnaG-CTD) interacts with the N-terminal domain of DnaB and stimulates 52 
the DnaB helicase activity (12). The stability of the interaction between DnaG primase and 53 
DnaB helicase varies among eubacteria. The helicase-primase interaction has been reported 54 
to be weak in Escherichia coli (13), moderate in Helicobacter pylori (14, 15) and strong in 55 
Bacillus stearothermophilus (9). Despite its relatively low resolution, the only available 56 
structure of the complex of DnaG-CTD with DnaB helicase in Bacillus stearothermophilus 57 
did provide insight into the helicase-primase interaction pattern (16). Since the helicase-58 
binding domain of primases is poorly conserved, we expect the structures from different 59 
organisms to provide insight into the mode of interaction between DnaG and DnaB.  60 
DNA replication in Mycobacterium tuberculosis (Mt) is not well understood. This 61 
intracellular pathogen is the main cause of human tuberculosis (17), and according to the 62 
recent World Health Organisation  report (WHO report 2017), tuberculosis is the leading 63 
cause of death from a single infectious agent. This pathogen can, under favorable conditions, 64 
hide in a dormant state in the host for long periods of time without producing conspicuous 65 
disease symptoms (18). Specifically, M. tuberculosis progresses to a state of non-replicating 66 
persistence to lie dormant in the host for such long periods of time (19). Mutations generated 67 
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by error-prone DNA replication also enhance M. tuberculosis virulence and lead to antibiotic 68 
resistance (20). Part of our lack of understanding of DNA replication in M. tuberculosis arises 69 
from the homologs of some essential proteins for efficient DNA replication in E. coli having 70 
not been identified in mycobacteria. In addition, the regulators of DnaA activity (Hda in E. 71 
coli, YabA in B. subtilis), replicative helicase loader protein (DnaC in E. coli, DnaI in B. 72 
subtilis) and replication terminator proteins (Tus in E. coli and RTP in B. subtilis), have not 73 
been characterized in M. tuberculosis (21-24). Recently, Rv0004 was found to have a role in 74 
M. tuberculosis DNA replication; it interacts with DNA and the DnaB (25). The mechanism 75 
by which the replisome of M. tuberculosis is formed from the DnaG-DnaB complex and 76 
various accessory proteins is still not clear. M. tuberculosis DnaB (MtDnaB) has recently 77 
been functionally characterized (26). The MtdnaB gene encodes 874 amino acid residues, 416 78 
of which (from Leu400 to Asn815) form an intein (27). An intein is an internal segment of 79 
amino acids that are excised from a protein precursor to generate a functional protein that 80 
splits off from the main protein during posttranslational maturation (27). The lack of 81 
structural data for the DnaB-DnaG complex and the incomplete structural information for the 82 
individual proteins are obstructing our efforts to understand the molecular details that 83 
reinforce this essential interaction in M. tuberculosis. However, the crystal structure of the 84 
NTD of MtDnaB has been reported (28). To further study the mode of interaction between 85 
MtDnaB and MtDnaG, we determined the structure of the helicase-binding domain of 86 
MtDnaG. 87 
The MtDnaG-CTD structure was observed to differ from the other available DnaG-CTD 88 
structures. We used crystal structures of MtDnaB-NTD reported earlier (28) and the currently 89 
determined structure of MtDnaG-CTD to derive a model of helicase-primase interactions in 90 
M. tuberculosis, and provided further evidence for this model by performing in vitro 91 
experiments We identified single amino acid residues at the helicase-binding domain of 92 
MtDnaG that, when mutated to alanine, resulted in proteins with altered interactions with 93 
DnaB helicase. Further analysis revealed the possibility of cross-species interaction of 94 
MtDnaB with other DnaG in eubacteria. Overall, these results substantially helped us to 95 
understand the mechanism of helicase-primase interactions specifically in M. tuberculosis 96 
and expand our knowledge on the diversity of bacterial DNA replication strategies, some of 97 
which may be organism specific. 98 
Materials and methods: 99 
4 
Cloning of expression constructs for heterologous expression: 100 
Mycobacterium tuberculosis (H37rv) genomic DNA and specific primers ( Table S1) were 101 
used for the polymerase chain reaction (PCR) to amplify the coding regions of MtdnaG-CTD 102 
(477 base pairs) and MtdnaB-NTD (591 base pairs). The amplified products of MtdnaG-CTD 103 
and MtdnaB-NTD were cloned into the Nhe1/Xho1 site of the expression vector pET21c 104 
(Novagen, Madison, WI, USA) and the Nde1/Xho1 site of the expression vector pET28b 105 
(Novagen, Madison, WI, USA), respectively, with each containing the C-terminal His6 tag. 106 
Similarly, dnaG-CTD from Vibrio cholerae (O395 strain) was cloned into the Nco1/Xho1 site 107 
of pET28b (Rehman thesis). DNA sequencing confirmed the sequences of all constructs. The 108 
cloning of HpdnaG-CTD and EcdnaG-CTD was performed previously in our laboratory (15, 109 
29). 110 
Site-directed mutagenesis 111 
MtDnaG-CTD mutants (MtDnaG-CTD I605A and MtDnaG-CTD F615A) were prepared by 112 
following a PCR-based method using the pET21c expression vector encoding for the wild-113 
type (MtDnaG-CTD) protein as a template. The amplification of the expression vector was 114 
performed using the KOD hot-start DNA polymerase (EMD Millipore), following the 115 
manufacturer guidelines, and specific pairs of primers (Table S1) were used for the 116 
introduction of the desired mutation. PCR products were treated with DpnI enzyme (New 117 
England Biolabs) and transformed into DH5α E. coli cells. The mutations were confirmed by 118 
performing DNA sequencing. 119 
Overexpression and purification of recombinant proteins: 120 
pET21c-MtDnaG-CTD and point mutant (MtDnaG-CTD I605A and MtDnaG-CTD F615A) 121 
constructs were transformed into E. coli BL21 (DE3). For expression, 1% of the overnight-122 
grown culture of a single colony was added to two liters of Luria-Bertani (LB) broth 123 
containing 100 μg/ml ampicillin, 1 mM glucose, and 1 mM MgCl2. Cells were grown to an 124 
optical density of 0.6 (in 600 nm wavelength) at 37°C. Overexpression of protein was 125 
induced overnight at 16°C with 0.5 mM isopropyl-beta-D thiogalactopyranoside (IPTG). The 126 
cells were harvested at 8,000 rpm for 5 min and mixed with lysis buffer A (30 mM Tris-HCl 127 
[pH 7.5], 150 mM NaCl, 5 mM imidazole, 5 mM MgCl2, 5 mM beta-mercaptoethanol 128 
[βME], 100 μM phenylmethylsulfonyl fluoride [PMSF]). After the addition of lysozyme (0.1 129 
mg/ml), the cell suspension was incubated at 4°C for 30 min. The cell suspension was 130 
sonicated (Branson Ultrasonic Systems) in an ice-water mixture at 25% of the amplitude with 131 
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a pulse of 20 seconds each interspersed with an interval of 30 seconds, and cell lysate was 132 
treated with 0.1% Triton X-100, followed by incubation for 30 minutes on a rotating rocker at 133 
4°C. The cell lysate was cleared by being subjected to centrifugation at 13,000 rpm for 45 134 
minutes at 4°C and then purified using Ni-NTA Sepharose resin (GE Healthcare, Sweden) 135 
pre-equilibrated in buffer A. Proteins were eluted with buffer B (30 mM Tris-Cl [pH 7.5], 136 
150 mM NaCl, 250 mM imidazole, 5 mM βME and 100 μM PMSF). The protein was then 137 
concentrated using an AmiconUltra-4 centrifugal filter ultracel-10K (Millipore, Billerica, 138 
MA, USA) and purified further by using a gel filtration chromatography Hi-Load Superdex-139 
75 16/60 column (GE Healthcare) pre-equilibrated with buffer C (30 mM Tris-Cl [pH 7.5], 140 
150 mM NaCl, 5% glycerol and 5 mM βME). Peak fractions were checked using SDS–12% 141 
PAGE and pooled together. 142 
HpDnaG-CTD and EcDnaG-CTD were purified as described earlier (15, 29). MtDnaB-NTD 143 
and VcDnaG-CTD constructs were transformed into E. coli BL21 (DE3) cells. Cells 144 
containing plasmids were grown in LB media in the presence of either 50 μg/ml kanamycin 145 
(MtDnaB-NTD) or 100 μg/ml ampicillin (VcDnaG-CTD) up to an OD600 of 0.6-0.8 at 37°C. 146 
Overexpression of protein was induced overnight at 20°C with 0.2 mM IPTG. Bacterial cell 147 
pellets were re-suspended in lysis buffer A and cells were disrupted by subjecting them to 148 
sonication. The lysate was cleared by subjecting them to centrifugation at 13,000 g for 45 149 
minutes at 4°C; and the proteins here were purified by being using Ni-NTA Sepharose beads 150 
pre-equilibrated in buffer A, and eluted with buffer B. Final purification was performed using 151 
gel filtration on a Hi-Load Superdex-75 16/60 column pre-equilibrated with buffer G (20 mM 152 
HEPES pH 7.4 and 150 mM NaCl). The homogeneity of protein was checked with (12%) 153 
SDS-PAGE.  154 
Overexpression and purification of the selenomethionine-labeled MtDnaG-CTD: 155 
Selenomethionine (Se-Met)-labeled MtDnaG-CTD was prepared to provide phases necessary 156 
for structure determination. Se-Met-labeled protein was purified under reducing conditions to 157 
prevent the formation of a mixture of reduced and oxidized Se-Met-labeled proteins. Protein 158 
labeling was carried out using media supplied by Molecular Dimensions. The concentration 159 
of selenomethionine was maintained at about 25 mg/liter. Initially, the primary culture of 160 
MtDnaG-CTD-transformed E.coli BL21 (DE3) was grown in LB medium overnight. The 161 
next morning, cells were harvested by centrifuging the overnight grown culture at 4,000 rpm 162 
for 5 minutes. The pellet obtained was resuspended in a purely selenomethionine medium and 163 
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the process was repeated once again to remove any traces of LB medium. After inoculation of 164 
the secondary culture in complete selenomethionine medium, the culture was allowed to 165 
grow for 4 hours until the OD600 reached 0.5 at 37°C. After this procedure, the cells were 166 
induced with 1 mM IPTG, and then shaken for another 8 hours at 30°C, followed by being 167 
harvested at 8,000 rpm for 3 minutes and stored at −80°C for downstream processing. The 168 
remaining steps of the purification were similar to those followed for the native MtDnaG-169 
CTD, as described above. 170 
Crystallization of MtDnaG-CTD:  171 
Native MtDnaG-CTD (6 mg/mL) and selenomethionine-labeled MtDnaG-CTD (5 mg/mL) 172 
were subjected to extensive crystallization trials using the hanging drop method. Initially, the 173 
automated machine MOSQUITO™ (AIRF, JNU) was used to set hanging crystallization 174 
drops containing 500 nL protein solution plus 500 nL reservoir solution in 96-well Greiner-175 
CELLSTAR plates for screening with Hampton and Molecular Dimensions crystallization 176 
screens. Small protein needles were grown using the reservoir solution of Hampton Peg Ion 177 
screen 25 (20% w/v PEG 3350, 0.2 M magnesium acetate tetrahydrate). The conditions were 178 
replicated and improved in 24-well Linbro plates by mixing 2 μl protein solution with 2 μl 179 
reservoir solution and equilibrating the resulting mixture against a 500 ml reservoir solution 180 
at 4°C. The best selenomethionine-labeled protein crystals were grown with a reservoir 181 
solution of 18% w/v PEG 3350, 0.15 M magnesium acetate and MOPS buffer pH 7.6. 182 
Crystals appeared after one week and grew to full size within two weeks. 183 
 184 
Data collection, processing and structure determination: 185 
The crystals were flash frozen in liquid nitrogen with a cryoprotectant solution containing 186 
20% PEG 400 mixed with mother liquor (18% w/v PEG 3350, 0.15 M magnesium acetate 187 
and MOPS buffer with pH 7.6). The X-ray data for Se-Met-labeled crystals were collected at 188 
the BM14 synchrotron beamline (ESRF, Grenoble, France) at a selenium peak wavelength of 189 
0.9786 Å. The data sets were indexed, integrated and scaled using HKL-2000 data processing 190 
software (30). The input diffraction data were prepared using programs of the CCP4 suite 191 
(31, 32). A partial structure was solved using the single wavelength anomalous scattering 192 
protocol of Auto-Rickshaw of the EMBL-Hamburg automated crystal structure determination 193 
platform ((33). Anomalous data were used to calculate FA values using the program 194 
SHELXC (34). Based on an initial analysis of the data, the maximum resolution for 195 
substructure determination and initial phase calculation was set to 2.0 Å. All of the three 196 
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heavy atoms expected (three selenomethionine atoms for each molecule of the asymmetric 197 
unit) were found using the program SHELXD (35). The correct hand for the substructure was 198 
determined using the programs ABS (36) and SHELXE (37). Initial phases were calculated 199 
after density modification using SHELXE. The initial phases were improved by carrying out 200 
density modification and phase extension to a resolution of 1.57 Å using the program 201 
RESOLVE (38). The initial model was built using the auto-build program ARP/wARP (39). 202 
The regions missing from this model were built manually using the COOT graphics package 203 
(40), and refinement of the resulting model was carried out with REFMAC5 (41). The 204 
structure was further improved after the iterative model building and refinement using COOT 205 
(42) and REFMAC5 (43), respectively. The final crystal structure was well refined with 206 
excellent electron density and validated by using PROCHECK (44) of the CCP4 suite. The 207 
figures presented here were generated using PyMOL (45). The data collection and refinement 208 
statistics are given in Table 1. Coordinate and structure factor files for the crystals of 209 
MtDnaG-CTD have been deposited with the Protein Data Bank under accession code PDB ID 210 
5Z51.  211 
 212 
Construction of the helicase-primase complex model in M. tuberculosis: 213 
The structure of MtDnaB-NTD reported earlier by the Tsodikov group (28) and our current 214 
structure of MtDnaG-CTD, as well as the structure of the BstDnaB-BstDnaG-CTD (helicase-215 
primase) complex (16) as a template, were used to model the MtDnaB-NTD/MtDnaG-CTD 216 
(helicase-primase) complex of M. tuberculosis. The structure of MtDnaB-NTD was 217 
superimposed on that of BstDnaB-NTD, and the globular region (GR) of MtDnaG-CTD was 218 
superimposed on the GR of BstDnaG-CTD of the complex. To superimpose the helical 219 
hairpin region (HHR) of MtDnaG-CTD with the HHR of the BstDnaB-BstDnaG-CTD 220 
complex, the HHR of MtDnaG-CTD was rotated by about 32°, keeping the linker between 221 
the HHR and the GR as the center of rotation, to obtain the lowest root mean square deviation 222 
(RMSD) between the BstDnaG-CTD and MtDnaG-CTD structures. This modification 223 
maximized the interactions between primase and helicase. The structure of the modeled 224 
complex was relaxed, by carrying out molecular energy minimization using the GROMACS 225 
molecular dynamics package (46), in order to eliminate bad contacts. Similarly, we 226 
constructed models of three complexes of MtDnaB-NTD, one with EcDnaG-CTD, and the 227 
other two with VcDnaG-CTD and HpDnaG-CTD, respectively, to study the possible 228 
interactions and stability levels of the heterocomplex. 229 
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Molecular dynamics simulation for binding affinity estimation: 230 
Molecular dynamics simulations were performed on the models of the MtDnaB-NTD 231 
complex with DnaG-CTD, DnaG-CTD I605A, and DnaG-CTD F615A, using the 232 
GROMACS 5.1.4 package, with the GROMOS 96 force field (47). To create the in silico 233 
mutants, isoleucine 605 and phenylalanine 615 were each changed to alanine using PyMOL 234 
(45) to make the two different DnaG-CTD mutants. These proteins were each solvated in a 235 
dodecahedron solvation box by using a simple point charge (SPC) (48) of water molecules. 236 
Na
+
 and Cl
−
 ions were included to neutralize the system. The energy was minimized using 237 
500 steps of steepest descent, followed by 1,000 steps of conjugate gradient. For maintaining 238 
the system in a stable environment (300 K, 1 bar), Berendsen temperature coupling (49) and 239 
Parrinello-Rahman pressure coupling (50) were employed and were set to 0.1 and 2.0 ps for 240 
temperature and pressure, respectively. A particle mesh Ewald (PME) algorithm (51) was run 241 
to measure the electrostatic and Van der Waals interactions; here, the cut-off distance for 242 
short-range VdW (rvdw) interactions was set to 1.4 nm, and Coulomb cut-off (r coulomb) 243 
and a neighbor list (rlist) was set to 0.9 nm. The LINCS algorithm (52) was used to measure 244 
all of the constrained bond lengths and the time step was set to 0.002 ps. The complexes in a 245 
medium were equilibrated for 100 ps in NPT and NVT ensembles. Finally, a 25 ns molecular 246 
dynamics simulation was carried out for each tested structure. All trajectories were stored 247 
every two ps for further analysis. Similar molecular dynamics simulation steps, as described 248 
above, were used on the three models of the complexes of MtDnaB-NTD, i.e., with EcDnaG-249 
CTD, HpDnaG-CTD, and VcDnaG-CTD. The binding free energies were calculated by using 250 
the molecular mechanics Poisson-Boltzmann surface area (MM/GBSA) method as 251 
implemented in  GROMACS tool (46). In our study, the free binding energy (ΔG) was 252 
calculated by using van der Waals (ΔEvdW), electrostatic (ΔEelec), polar solvation (ΔGpolar) and 253 
nonpolar (ΔGnon-polar) energy contributions. 254 
Biosensor binding studies: 255 
To determine the difference between the binding affinity of MtDnaB-NTD for MtDnaG-CTD 256 
and those of MtDnaB-NTD for the MtDnaG-CTD mutants and other bacterial DnaG-CTDs, 257 
biosensor-based binding experiments were performed using an Autolab surface plasmon 258 
resonance (SPR) instrument at the Advanced Instrumentation Research Facility, Jawaharlal 259 
Nehru University, New Delhi, India. The surface of SPR chip (a self-assembled monolayer of 260 
11-mercaptoundecanoic acid [MUA] on a gold surface; Autolab) was first activated with 261 
carbodiimide (EDC; 0.2 M) and N-hydroxysuccinimide (NHS; 0.05 M)/N-ethyl-N-(diethyl 262 
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aminopropyl). MtDnaG-CTD, MtDnaG-CTD mutants, and other bacterial DnaG-CTDs were 263 
immobilized (separately on different chips) onto the activated sensor surface at a 264 
concentration of 20 μg/ml in filtered (0.22-μm pore size) and degassed 10 mM sodium 265 
acetate buffer (pH 4.5). The chip had two channels: channel one was used for immobilization 266 
of ligand; and channel two was used as a blank (the signals of the analyte with a ligand-free 267 
surface). After ligand immobilization, the surface was blocked with 100 mM ethanolamine at 268 
pH 8.5, followed by regeneration using 1 M NaCl. The running buffer constituents were the 269 
same as those recommended for HBS BIAcore running buffer (10 mM HEPES [pH 7.4], 150 270 
mM NaCl, 3 mM EDTA, 0.05% P-20 surfactant). The association kinetics for DnaG-CTDs 271 
was monitored for 400 seconds, followed by monitoring of the dissociation kinetics for the 272 
next 300 seconds. MtDnaB-NTD samples of various concentrations were prepared in running 273 
buffer and injected at the rate of 20 μl/min across the sensor surface. The concentrations of 274 
MtDnaB-NTD used against MtDnaG-CTD were 1500, 1000, 750, 500, 250 and 125 nM, 275 
whereas, for the MtDnaG-CTD mutants and other bacterial DnaG-CTDs, the concentrations 276 
used were 2000, 1500, 1,000, 750, 500 and 250 nM. Bovine serum albumin protein samples 277 
at various concentrations (2000, 1500, 1,000, 750, 500 and 250 nM) were used as negative 278 
controls. Signal changes on the activated/blocked control panel were subtracted from the 279 
DnaG-DnaB binding interactions using an inline reference signal, and the subtracted 280 
sensorgrams were analyzed. The surface was regenerated with a buffer consisting of two 281 
manually delivered pulses of 1 M NaCl. All of the data were recorded at 25°C. The data 282 
analysis was performed using Autolab SPR kinetic evaluation software.  283 
Results: 284 
The overall structure of MtDnaG-CTD:                                              285 
To obtain a more detailed view of the interaction between the helicase and primase of 286 
Mycobacterium tuberculosis, we set out to determine a high-resolution crystal structure of the 287 
helicase-binding domain of MtDnaG (MtDnaG-CTD) and indeed did so, to a resolution of 288 
1.58 Å (Fig. 2b). Molecular replacement failed to give any solution, indicative of the low 289 
homology and structural similarity with all of the previously determined DnaG-CTDs. Se-290 
Met-labeled protein crystals were used to obtain anomalous data and experimental phases. 291 
The Se-Met-labeled protein crystal diffracted X-rays to 1.58 Å at BM14 of ESRF and 292 
belonged to the space group P21212 with cell dimensions of a = 48.2 Å, b = 137.5 Å, c = 36.5 293 
Å (α= β= γ = 90°). The final model yielded an R factor of 18.1% and Rfree of 20.8%, with good 294 
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electron density (Fig. 2a). One complete MtDnaG-CTD (residues 481 to 637) and one helical 295 
hairpin cleaved from the MtDnaG-CTD (residues 569 to 637) were identified per asymmetric 296 
unit (Fig. 2b) and these two protein chains were stabilized with a few van der Waals 297 
interactions (Fig. 2d). The overall CTD structure of MtDnaG displayed two subdomains, the 298 
N-terminal globular region (GR) subdomain (residues 482 to 562) and C-terminal helical 299 
hairpin region (HHR) subdomain (residues 568 to 637), connected by a small loop (6 300 
residues) (Fig. 2c). Inspection of the MtDnaG-CTD structure showed it to lack any beta sheet 301 
and to consist instead primarily of alpha helices, specifically ten of them with the first eight 302 
forming the GR and the last two forming the HHR (Fig. 2c). The gel filtration 303 
chromatography profile of MtDnaG-CTD in solution on a calibrated Superdex G75 16/60 304 
column revealed a sharp elution peak at 70.3 ml, and an observed molecular weight of ∼38 305 
kDa, indicating MtDnaG-CTD (∼19 kDa) to exist in a dimeric state in solution (Fig. 1). 306 
Electron density corresponding to the GR or N-terminal residues (residues 481 to 568) of 307 
MtDnaG-CTD was not visible in one monomer due to the cleavage of MtDnaG-CTD. 308 
MtDnaG-CTD cleaved into two fragments (GR and HHR), and the fragments were also 309 
identified using MALDI-TOF (Fig. S2). A total of 232 amino acid residues, one polyethylene 310 
glycol (PEG) molecule, one acetate molecule and 320 water molecules were determined to be 311 
present per asymmetric unit. A Ramachandran analysis showed 99.1% of the residues in the 312 
favored region, 0.5% in the generously allowed region, and 0.4% in the disallowed region.  313 
The MtDnaG-CTD structure differs from other DnaG-CTD structures in the HHR:  314 
The 1.58-Å resolution of the current M. tuberculosis DnaG-CTD structure was higher than 315 
those of the other four available DnaG-CTD crystal structures, i.e., those determined for E. 316 
coli (resolution to 2.8 Å, PDB ID 1T3W), B. stearothermophilus (2.9 Å, 2R6A), H. pylori 317 
(1.7 Å, 4EHS) and V. cholerae (2.4 Å, 4IM9) (15, 16, 53). Structural alignments of MtDnaG-318 
CTD with these structures were done, using LSQMAN (54), to evaluate the differences 319 
between them. We specifically aligned the GRs of these structures to show the diversity in 320 
the relative orientation of the HHR. (Fig. 3). The RMSDs between MtDnaG-CTD and 321 
EcDnaG-CTD, BstDnaGCTD, HpDnaG-CTD, and VcDnaG-CTD were found to be 1.89 Å 322 
(45 Cα atoms), 1.85 Å (71 Cα atoms), 1.59 Å (62 Cα atoms), and 1.77 Å (43 Cα atoms), 323 
respectively. However, DnaG-CTDs have been found to share less than 10% sequence 324 
identity (Fig. S1). The total structural alignments of MtDnaG-CTD with EcDnaG-CTD, 325 
BstDnaGCTD, HpDnaG-CTD, and VcDnaG-CTD using RAPIDO (55) yielded RMSDs of 326 
12.58 Å (101 Cα atoms), 6.81 Å (131 Cα atoms), 5.24 Å (108 Cα atoms) and 4.28 Å (122 Cα 327 
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atoms), respectively (Table S2). Inspection of the superpositions of these structures suggested 328 
the GR of MtDnaG-CTD to be structurally more similar to that of HpDnaG-CTD than to 329 
those of the other DnaG-CTDs. Overall, the arrangement of helices in MtDnaG-CTD was 330 
observed to be similar to that in VcDnaG-CTD (Table S2). The number of alpha helices 331 
present in each CTD structure was also found to differ: ten helices in the MtDnaG-CTD 332 
structure, six each for HpDnaG-CTD and VcDnaG-CTD, and seven each for EcDnaG-CTD 333 
and BstDnaG-CTD (Fig. S4). These differences in the number of alpha helices resulted for 334 
the most part in offsets between the boundaries of the helices in the structure-based alignment 335 
(Fig. 3). Comparison of the MtDnaG-CTD structure with other DnaG-CTD structures showed 336 
a larger deviation between the entire structures than between the GRs. The HHRs from the 337 
different sources adopted different orientations relative to the GRs and showed much greater 338 
structural differences than did the GRs. Moreover, the B factors of the HHRs and linkers 339 
were found to, in general, be greater than those of the GRs (Table S3), indicating relatively 340 
high flexibility levels for the HHR and linker regions. Also, note the lower overall B-factor of 341 
the MtDnaG-CTD structure than of the other known CTD structures (Table S3). Interestingly, 342 
despite all of the DnaG-CTD structures consisting of a GR as well as HHR, multiple 343 
sequence alignment (MSA) of amino acid sequences (Fig. S1b) and structural alignment did 344 
not yield any significant homology. 345 
MtDnaG-CTD interacts at the dimer-dimer interface of MtDnaB-NTD using mostly 346 
hydrophobic residues of the HHR: 347 
A previous investigation showed MtDnaB-NTD (residues 21–197, including the linker) to 348 
form a stable dimer in solution, and a truncated form of the protein (residues 21–134) to be 349 
monomeric, indicating the region spanning residues 135–197 to be required for dimer 350 
stability (28). Therefore, we also generated these monomeric and dimeric MtDnaB-NTD 351 
constructs, using the same method as described earlier (28), for our studies. Specifically, 352 
biosensor binding studies of each of these two constructs with MtDnaG-CTD was carried out 353 
using surface plasmon resonance by passing the respective MtDnaB-NTD construct on 354 
immobilized MtDnaG-CTD. The results of these two experiments showed MtDnaG-CTD to 355 
not interact with the monomeric form of MtDnaB-NTD (Fig. S3b) but to do so with the 356 
dimeric form (Fig. S3c). 357 
The lack of a high-resolution structure of the DnaB-DnaG complex and the fragmented 358 
structural information for the individual proteins have impeded our attaining a detailed 359 
understanding of this crucial binary protein interaction. The only complex structure of the 360 
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active hexameric BstDnaB (PDB: 2R6A) was determined as a trimer of dimer and three 361 
BstDnaG-CTDs were found at the dimer-dimer interface of BstDnaB (16).  Similarly, the 362 
crystal structure of the MtDnaB-NTD (PDB: 2R5U) has been reported to form a hexameric 363 
ring having two distinct interfaces; an extensive hydrobhobic interface, stabilizing a dimer 364 
(monomer-monomer) of MtDnaB-NTD, and other less extensive interface formed between 365 
the dimers, connecting three of them into a hexamer (28). The dimer-dimer interface of 366 
MtDnaB-NTD was considered as a DnaG binding site (28). Here, we produced a model of the 367 
M. tuberculosis DnaB-DnaG complex by one molecule of MtDnaG-CTD interacted to two 368 
molecules of MtDnaB-NTD, involved at the dimer- dimer interface similar to BstDnaB-369 
DnaG-CTD complex structure (16). Superimpositions of the GR of the MtDnaG-CTD crystal 370 
structure with GRs from the crystal structures of EcDnaG-CTD, VcDnaG-CTD, BstDnaG-371 
CTD, and HpDnaG-CTD respectively (Fig. 3), showed the orientation of the HHR to vary 372 
considerably between the different species and suggested the flexibility of the HHR. 373 
Inspection of the HHR in the unbound form of BstDnaG-CTD showed it to be oriented 65° 374 
away from its orientation in the helicase-bound form (Fig. S5a), and this difference was 375 
attributed to the flexibility of the HHR. Therefore, the HHR of MtDnaG-CTD was rotated by 376 
32° to model the MtDnaG-CTD/MtDnaB-NTD complex using the BstDnaB/DnaG-CTD 377 
(PDB: 2R6A) complex structure as a template (Fig. S5). A molecular dynamics simulation of 378 
the model was carried out for 25 nanoseconds and revealed the stability of the model after the 379 
first few nanoseconds of the simulation (Fig. 4c). When producing our model of the MtDnaG-380 
CTD/MtDnaB-NTD complex, we maximized the number of interactions between the HHR of 381 
MtDnaG-CTD and MtDnaB-NTD (Fig. 4a). DnaG mutations in the part of the extreme C-382 
terminal region,  containing the HHR, were shown to be disruptive to the DnaB–DnaG 383 
complex (56), hence indicating this part of the C-terminal region to be crucial for the 384 
helicase-primase interaction. Our modeling highlighted the amino acid residues present in the 385 
helicase-primase complex interface that may participate in these crucial interactions and 386 
stabilize the complex (Fig. 4a). The low homology between the DnaG-CTD sequences (Fig. 387 
S1a) together with the presence of different yet consistently hydrophobic amino acid residues 388 
at the M. tuberculosis (Fig. 4a, 5b) and B. stearothermophilus (16) helicase-primase interface 389 
suggests the involvement of hydrophobic interactions in stabilizing the helicase-primase 390 
complex. According to the model, I605 and F615 from the primase of M. tuberculosis make 391 
extensive hydrophobic interactions with helicase, and these residues, in particular, may be 392 
playing a crucial role in stabilizing the helicase-primase complex (Fig. 4b). 393 
 394 
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Ile605 in the HHR is crucial for helicase-primase interaction in Mycobacterium 395 
tuberculosis: 396 
To elucidate the main drivers of the helicase-primase association and to identify hotspots, we 397 
turned to quantify individual contributions of potential key residues, guided by a structural 398 
analysis of our proposed M. tuberculosis DnaG-CTD/DnaB-NTD complex model. To 399 
accomplish this goal, we mutated a couple of crucial contact residues modeled to be present 400 
at the interface of the M. tuberculosis DnaG-DnaB complex. Inspection of our model (Fig. 401 
4a) indicated a large non-conserved hydrophobic residue, Ile605, to be the most prominent 402 
surface-accessible hydrophobic residue on the HHR of MtDnaG-CTD (Fig. 4b). Inspection of 403 
our model indicated Ile605, of the loop connecting αH9 and αH10 of the HHR, to be 404 
stabilizing the complex. Ile605 present at the crucial position, flexible loop within the HHR, 405 
through that the whole HHR get hooked by this residue. Our analysis also indicated Phe615, 406 
another large hydrophobic residue of MtDnaG-CTD, to be present at the M. tuberculosis 407 
DnaG-DnaB interface (Fig. 4b). This residue, being present at helix 10 of MtDnaG-CTD, was 408 
observed to be less accessible than MtDnaG-CTD Ile605 present at the connecting loop of the 409 
HHR. The stability levels of the helicase (MtDnaB-NTD) in complex with native MtDnaG-410 
CTD, mutant MtDnaG-CTD F615A, and mutant MtDnaG-CTD I605A were analyzed by 411 
carrying out molecular dynamics simulations (Fig. 4c). Furthermore, the binding energy 412 
levels of all of the complex models were calculated using the MM/GBSA method of 413 
GROMACS (Table S4). The binding energy values of helicase (MtDnaB-NTD) in complex 414 
with native MtDnaG-CTD, mutant MtDnaG-CTD F615A, and mutant MtDnaG-CTD I605A 415 
were -100 kjoule/mol, -75.3 kjoule/mol and -60 kjoule/mol, respectively (Table S4). The 416 
binding affinities for the native and mutant MtDnaG-CTDs in complex with MtDnaB-NTD 417 
were also measured in vitro using surface plasmon resonance (SPR) spectroscopy (Fig. 5). 418 
Native and mutant MtDnaG-CTDs were immobilized on three different chips under identical 419 
conditions, and different concentrations of MtDnaB-NTD were passed as an analyte with 420 
HBS buffer over the immobilized proteins. The KD values of MtDnaB-NTD in complex with 421 
MtDnaG-CTD, MtDnaG-CTD F615A, and MtDnaG-CTD I605A were measured to be 370 422 
nM, 444 nM, and 2.8 µM, respectively (Fig. 5). The SPR results indicated a 10-fold decrease 423 
in the binding affinity of MtDnaB-NTD with MtDnaG-CTD I605A compared to that of 424 
MtDnaB-NTD with native MtDnaG-CTD. Although the measured difference in binding 425 
affinity to the native (MtDnaG-CTD) and mutated (MtDnaG-CTD I605A) proteins was 426 
relatively large considering that only a single residue was mutated, there was still observed 427 
significant affinity between the helicase and the mutated (MtDnaG-CTD I605A) primase. In 428 
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our current study, we noticed the important role of the loop connecting the two helices of the 429 
HHR in stabilizing the helicase-primase complex. This major role of the loop within the HHR 430 
in the stability of the helicase-primase complex was indicated despite no common amino acid 431 
residues present at the same position of different DnaG-CTDs. Both in silico calculations and 432 
in vitro experiments (SPR) suggested a significant role of Ile605 of MtDnaG in the 433 
stabilization of the helicase-primase (MtDnaB/MtDnaG) complex in M. tuberculosis. 434 
    435 
Mycobacterium DnaB-NTD interacts to DnaG-CTD of other organisms with low binding 436 
affinity:  437 
The helicase-binding domain of DnaG and primase-binding region of DnaB are the least 438 
conserved regions of their respective proteins. Despite the insignificant homology between 439 
the various DnaG-CTD sequences, the DnaG-CTD structures were found to be similar, 440 
especially in their all having globular and HHR regions. A functional complementation of 441 
EcDnaB with HpDnaB has been reported earlier (57), indicative of an interaction between 442 
HpDnaB with EcDnaG. To further test whether the cross-species helicase-primase interaction 443 
takes place even with such a low sequence similarity, we performed a study of the interaction 444 
of MtDnaB-NTD with other DnaG-CTDs. We studied the specificity in the interaction of 445 
DnaB with non-cognate DnaG by generating an in silico model of the complex and further 446 
tested the biophysical interactions of Mycobacterium DnaB-NTD with other DnaG-CTDs, 447 
i.e., from E. coli, H. pylori, and V. cholerae. The steps used to in silico build and analyze the 448 
models of MtDnaB-NTD in complex with DnaG-CTDs from E. coli, H. pylori, and V. 449 
cholerae (Fig. 6) were similar to the strategy used in producing the model of the M. 450 
tuberculosis helicase-primase complex. The free energy values of the binding of native 451 
MtDnaB-NTD to EcDnaG-CTD, HpDnaG-CTD, and VcDnaG-CTD were -13.7 kJ/mol, -71.5 452 
kJ/mol and -58.4 kJ/mol respectively. The in silico studies suggested the MtDnaB-453 
NTD/HpDnaG-CTD complex to be more stable than the MtDnaB-NTD/EcDnaG-CTD and 454 
MtDnaB-NTD/VcDnaG-CTD complexes. We also carried out biosensor binding studies using 455 
surface plasmon resonance (SPR) spectroscopy. Specifically, the binding affinities of native 456 
MtDnaB-NTD for EcDnaG-CTD, HpDnaG-CTD, and VcDnaG-CTD were measured in vitro 457 
using SPR spectroscopy. The KD values for the complexes of MtDnaB-NTD with EcDnaG-458 
CTD (Fig. 7a) and HpDnaG-CTD  (Fig. 7b) were determined from these studies to be 7.4 µM 459 
and 3.4 µM, respectively, while MtDnaB-NTD formed an unstable association with VcDnaG-460 
CTD (Fig. 7c). However, the cross species helicase-primase binding did not show the order 461 
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as predicted by the in silico studies. But both in silico as well as in vitro cross- study on 462 
MtDnaB-NTD to DnaG-CTD of other bacteria showed the significant decrease in binding 463 
affinities compared to the binding affinity of native MtDnaG-CTD and MtDnaB-NTD 464 
interaction. Moreover, the decrease in the binding affinity of DnaG to DnaB might affect the 465 
activity of these proteins during the replication process.  466 
 467 
Discussion 468 
In this study, the crystal structure of the DnaB helicase-binding domain of DnaG primase 469 
(MtDnaG-CTD) of Mycobacterium tuberculosis was determined to gain insight into the 470 
helicase-primase interaction, crucial for the survival of eubacteria. The complex between the 471 
DnaG primase and the DnaB helicase unwinds duplex DNA at the eubacterial replication fork 472 
and synthesizes the RNA primers required for initiation of DNA replication (58, 59). An 473 
alignment of DnaG-CTD sequences showed high diversity. Therefore, the MtDnaG-CTD 474 
crystal structure could not be solved using molecular replacement, and we instead used SAD 475 
phasing. Analysis of the determined structure highlighted the flexibility of the DnaG-CTD 476 
scaffold, which has been observed in other DnaG-CTDs, and supported the existence of hinge 477 
bending within the protein. The hinge point located in the linker between the globular region 478 
(GR) and hairpin region (HHR) apparently allows these two regions of the protein to become 479 
close together or far apart, resulting in an alternation between elongated and contracted 480 
shapes. Also, the flexibility of the helicase-binding domain has been shown to be due in large 481 
part to the identified hinge point, and to be the main factor maximizing the interactions with 482 
DnaB helicase. A comparison of MtDnaG-CTD with other DnaG-CTD structures suggested 483 
some degree of conservation of the protein fold, in particular in the GR. Overall; the HHR 484 
appears to have the major role in the interaction with DnaB and shows a high degree of 485 
diversity in eubacteria.  486 
We also constructed in silico a hypothetical model of the MtDnaB-NTD/MtDnaG-CTD 487 
complex, based on the BstDnaB/DnaG-CTD complex crystal structure (16), and found the 488 
hypothetical model to be consistent with previous mutagenesis studies (56). In the model of 489 
the MtDnaB-NTD/MtDnaG-CTD complex, the HHR of MtDnaG-CTD covers the interface 490 
otherwise making dimer-dimer interactions in the hexameric form MtDnaB-NTD. Also, 491 
Ile605 and Phe615 are large non-conserved hydrophobic residues present at the HHR of 492 
MtDnaG and, according to our model, interact with MtDnaB (Fig. 4a). Our analysis also 493 
indicated Ile605, a hydrophobic residue present on the loop of the HHR of MtDnaG-CTD, to 494 
interact with Val82 and Ala85 of MtDnaB-NTD and hence to be crucial for the formation of 495 
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the complex. Our in silico study of the MtDnaB/MtDnaG complex also indicated a decrease 496 
in binding energy upon mutation of MtDnaG-CTD Ile605 to alanine as well as upon the 497 
mutation of its Phe615 to alanine (Table S4). To provide further evidence for the results of 498 
these binding affinity calculations, we also carried out in vitro studies involving expressing 499 
both mutants of MtDnaG-CTD and using SPR spectroscopy to measure their affinities for 500 
DnaB-NTD. In this biosensor binding study, the affinity of the Ile605Ala MTDnaG-CTD 501 
mutant for MtDnaB-NTD was shown to be ten times weaker than the affinity of the native 502 
MtDnaG-CTD for MtDnaB-NTD. These findings helped us validate the model and identify 503 
Ile605 as one of the key MtDnaG residues stabilizing the association of MtDnaG with 504 
MtDnaB. 505 
Analysis of our current structure, biosensor results and the results of the previous studies of 506 
DnaB-DnaG complexes (15, 16) led us to conclude that the loop connecting the two helices 507 
of the HHR is apparently largely responsible for the stability of this complex. The sequence 508 
and structural analysis indicated the non-conserved residue Ile605, present at the helical 509 
hairpin loop of DnaG, to be specific to M. tuberculosis and to be a key residue for the 510 
interaction between DnaB and DnaG (Fig. 4). The earlier study in  H. pylori, residue Phe537 511 
of the helical hairpin loop of DnaG-CTD has been shown to play a key role in the stability of 512 
the DnaB-DnaG complex (15). The observation of amino acid residues present at the helical 513 
hairpin loop of DnaG-CTDs suggested the presence of non-conserved hydrophobic residues 514 
that play a significant role in the stability of the DnaB-DnaG complex. The flexibility of the 515 
loop apparently allows for maximizing the access of its hydrophobic residues for contacts 516 
with DnaB-NTD. 517 
The binding affinity of MtDnaB for MtDnaG was measured to be in the nanomolar range 518 
while the binding affinities of MtDnaB with other DnaGs from different species were 519 
measured in the micromolar range (Fig. 5, Fig. 7). Such a relatively low level of heterologous 520 
binding affinity might be expected to result in relatively poor helicase and primase activities 521 
in the case of complementarity with other organisms. A suboptimal activity level of any DNA 522 
replication initiation protein would, in turn, be expected to slow down replication fork 523 
progression (2). Though the helicase of H. pylori showed functional complementarity with E. 524 
coli (57), such complementarity of this helicase seems to be specific to just a few organisms. 525 
Therefore, MtDnaB may show complementarity with E. coli and H. pylori but not in V. 526 
cholerae. The pattern of interactions between DnaG and DnaB seems to vary from one 527 
organism to the next, and therefore any change in the affinity between these proteins may 528 
affect not only the initiation of replication but also overall DNA replication.  529 
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Based on the crystal structure and our model, we can suggest a possible mechanism to 530 
explain the regulation of DnaB-DnaG activity at the replication fork. Bacterial primases 531 
primarily adopt a compact state but can transition to an extended conformation (60). In the 532 
unbound form or free form of DnaG, the HHR may fold back to interfere with the RNA 533 
polymerase domain or the Zn-binding domain. According to the proposed mechanism, the 534 
moment when DnaG-CTD comes into contact to helicase the GR side of DnaG-CTD might 535 
interact to the one molecule of MtDnaB-NTD and this binding might enforce for the changing 536 
the orientation of HHR from the unbound state of DnaG. The HHR would bend in such a way 537 
as to properly bind to the second molecule of DnaB-NTD with comparatively stronger than 538 
first one, and the bending of the HHR away from the RNA polymerase domain or Zn-binding 539 
domain may lead to the activation of primase by coming into contact with DnaB. Because 540 
DnaG cannot effectively function as an independent molecule, i.e., unbound from DnaB, this 541 
mechanism would also provide a means to prevent unwanted priming at non-replicative sites 542 
in the cell. Future studies to further address this model in the context of the replisome will 543 
highlight how interactions between DnaG and the rest of the replisome synergize to regulate 544 
replication of the lagging strand. 545 
In conclusion, the structural and biophysical data provided by our work have shed new light 546 
on the structural assembly and mode of binding of DnaG-CTD with DnaB-NTD in M. 547 
tuberculosis and unveiled mechanistic details and selectivity determinants for other 548 
eubacteria. The non-conserved interacting domains of DnaG-DnaB complex expand the study 549 
on the aspects of the species-specific evolution of the replication system. 550 
 551 
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Table 1: Crystallographic data and refinement statistics:  733 
 734 
 735 
 736 
 737 
 738 
 739 
 740 
 741 
 742 
 743 
 744 
Crystallographic data 
X-ray source BM14, ESRF, France  
Wavelength (Å) 0.97 
Space group P2
1
2
1
2 
Unit cell parameters 
a, b, c (Å) 48.28, 137.55, 36.51 
α, β, γ (º) 90, 90, 90 
Resolution range (Å) 68.78 -1.58   
Completeness (%) 92.8 (99.8) 
Total no. of observations 150161 
No. of unique observations 40035 
Redundancy 3.8 (3.9) 
Average I/σ (I) 19.66 (1.94) 
 CC (1/2) 0.92 (0.72) 
Rr.i.m. 0.088 
Crystal mosaicity (º) 0.76 
Refinement 
  
R-factor (%) 18.14 
Free R-factor (%) 20.88 
Mean B factor (Å
2
)  16.1  
Number of atoms 
Protein/PEG/acetate/water 1812/17/7/320 
  RMS deviation 
Bond length (Å) 0.017 
Bond angles (°) 1.64 
Ramachandran plot (%) 
In preferred region 99.1 
In allowed region 0.5 
Outliers 0.4 
PDB ID 5Z51 
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Figure legends: 745 
 746 
Fig. 1:  MtDnaG-CTD is a dimer in solution. (a) Size-exclusion chromatograph of the C-747 
terminal domain of primase (MtDnaG-CTD) passed through a HiLoad 16/60 Superdex 75 748 
column. Ten-milliliter fractions were collected. The elution volume (70.3 ml) and the elution 749 
pattern of the protein are displayed. (b) The molecular mass of the eluted DnaG-CTD was 750 
deduced from the standard plot to be about ∼ 35kDa, corresponding to the dimeric state of 751 
the protein. (c) SDS-PAGE showing fractions purified by gel filtration. The proteins were 752 
separated on SDS–12% PAGE and stained with Coomassie brilliant blue. Lane M shows the 753 
molecular markers; lane P shows the gel filtration fraction. 754 
Fig. 2: Crystal structure of MtDnaG-CTD. (a) A portion of the molecule shown with a 755 
2Fo-Fc electron density map contoured at 1σ within 1.5 Å of selected atoms. (b) Cartoon 756 
diagram showing the crystal structure of the MtDnaG primase CTD. The overall structure 757 
was observed to have one globular region connected to the helical hairpin region by a flexible 758 
loop. Chain A is colored purple, and chain B is cyan. One complete MtDnaG-CTD (chain A) 759 
and one helical hairpin cleaved from this CTD (chain B) were identified per asymmetric unit. 760 
(c) Cylindrical representation of the MtDnaG-CTD crystal structure showing the arrangement 761 
of the ten helices connected by loops. Helices αH1 - αH8 formed the globular region and 762 
helices αH9 – αH10 formed the helical hairpin region. (d) Amino acid residues showed the 763 
hydrophobic interaction between the chain A and chain B in the crystal structure of MtDnaG-764 
CTD. 765 
Fig. 3: Superpositions of the globular region of MtDnaG-CTD with the globular regions 766 
of other DnaG-CTDs provided insight into the differences in the shapes and 767 
orientations of HHRs. Superposition of the globular region of the MtDnaG-CTD (purple) 768 
crystal structure with the globular region of  each of (a) EcDnaG-CTD (green), (b) VcDnaG-769 
CTD (cyan), (c) BstDnaG-CTD (violet) and (d)HpDnaG-CTD (wheat). The helical hairpin 770 
regions (HHRs) of the different structures showed different orientations.  771 
Fig. 4: Model of the M. tuberculosis helicase-primase complex. (a) Model of the M. 772 
tuberculosis helicase-primase complex. Experimentally determined structures of MtDnaB-773 
NTD (PDB: 2R5U) and MtDnaG-CTD (PDB: 5Z51), as well as that of the BstDnaB-774 
BstDnaG-CTD complex (PDB: 2R6A), were used to generate the model of the complex. In 775 
the complex model, two molecules of DnaB-NTD interacts with one molecule of DnaG-CTD. 776 
25 
The model was further relaxed to eliminate bad contacts using molecular energy 777 
minimization with the help of the GROMACS molecular dynamics package. (b) The crucial 778 
residues of the helical hairpin showing hydrophobic interactions stabilizing the helicase-779 
primase complex. (c) RMSD analysis of the trajectories of native and mutants primase 780 
models. Time-dependent Cα RMSDs for all residues of DnaB-NTD complexed with the 781 
native DnaG-CTD (black), I605A mutant DnaG-CTD (red), and F615A mutant DnaG-CTD 782 
(green) showed structural convergence from the initial time point. No effect of the mutations 783 
on the DnaG-CTD structure was observed, but a significant effect on the binding affinity of 784 
the helicase for the primase was found.  785 
Fig. 5: SPR sensorgram for measuring the binding affinity of the helicase for the 786 
primase. Sensorgrams showing the binding pattern of MtDnaB-NTD at various 787 
concentrations (legends) with immobilized (a) native MtDnaG-CTD, (b) F615A mutant 788 
MtDnaG-CTD, and (c) I605A mutant MtDnaG-CTD. The mutation of a single residue, Ile605 789 
to Ala, on the helicase-binding surface resulted in an almost 10-fold decrease in the binding 790 
affinity. 791 
Fig. 6: In silico investigations of the cross-species helicase-primase complexes. (a-c) 792 
Experimentally determined structures of MtDnaB-NTD (PDB: 2R5U) and (a) EcDnaG-CTD 793 
(PDB: 1T3W), (b) HpDnaG-CTD (PDB: 4EHS) and (c) VcDnaG-CTD (PDB: 4IM9) were 794 
used to generate models of the helicase-primase complex. In each case, the crystal structure 795 
of the BstDnaB-BstDnaG-CTD (PDB: 2R6A) complex was used as a template. The model 796 
was further relaxed to eliminate bad contacts using molecular energy minimization with the 797 
help of the GROMACS molecular dynamics package. (d) RMSD analyses of the trajectories 798 
of the three models. Time-dependent Cα-RMSDs for all residues of DnaB-NTD complexed 799 
with EcDnaG-CTD (red), HpDnaG-CTD (black) and VcDnaG-CTD (green) showed 800 
structural convergence from the initial time point.There were no structural changes during the 801 
dynamics simulation, but the DnaB-DnaG binding affinities for the cross-species complexes 802 
differed significantly from that for the native M. tuberculosis DnaB-DnaG complex. 803 
Fig. 7: SPR sensorgrams for measuring the binding affinities of helicase with non-804 
cognate primases. Sensorgrams showing the binding patterns of MtDnaB-NTD at various 805 
concentrations (legends) with immobilized (a) E. coli DnaG-CTD, (b) H. pylori DnaG-CTD 806 
and (c) V. cholerea DnaG-CTD. The results indicated MtDnaB-NTD to weakly bind 807 
EcDnaG-CTD and HpDnaG-CTD, and unstably interact with VcDnaG-CTD.  808 
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Supporting Data 
Supplementary Fig. 1: DnaG primase. (a) Domain organization of DnaG primase. DnaG 
has three domains: zinc-binding domain for DNA binding, polymerase domain for primer 
synthesis, and C-terminal domain for helicase binding. The sequences of the zinc-binding 
domain and polymerase domain are conserved in DnaG primases, but the helicase-binding 
domain shows high variation. (b) Multiple sequence alignment of DnaG-CTD or helicase-
binding domain shows insignificant homology. 
Supplementary Fig. 2: Cleavage of MtDnaG-CTD into two fragments. (a) About a week 
old purified MtDnaG-CTD protein was loaded into 15% SDS-PAGE, yielded three bands, 
indicating part of the protein sample was cleaved into two fragments. This experiment 
confirms the crystal structure, where cleaved HHR fragment and DnaG-CTDs assembled into 
one assymmetric unit. The three bands indicate full-length CTD, lower twin bands represent 
globe region and HHR. (b) MALDI analysis of all three bands confirmed the cleavage of 
MtDnaG-CTD into two fragments.  
Supplementary Fig. 3: SPR sensorgram:  (a) SPR sensorgram for measuring the binding 
pattern of BSA with different concentrations of MtDnaB-NTD as a negative control. SPR 
sensorgrams showing the binding pattern of MtDnaG-CTD with different concentrations of 
(b) monomeric MtDnaB-NTD and (c) dimeric MtDnaB-NTD. Only dimeric DnaG-CTD 
showed a pattern indicative of binding DnaB-NTD. 
 
Supplementary Fig. 4: Cartoons showing the helices in crystal structures of the DnaG 
primase C-terminal domain. Cylindrical representation of (a) EcDnaG-CTD, (b) BstDnaG-
CTD, (c) HpDnaG-CTD and (d) VcDnaG-CTD showing the total number of helices present 
in each of the different DnaG-CTDs.  
*X is very small (three residues) and it was not considered as a complete helix. 
Supplementary Fig. 5: The helical hairpin region adopts different orientations in the 
free and bound states. Alignments of the globular regions (GRs) of the DnaG-CTDs gave 
insight into the differences in the shapes and orientations of the HHRs. (a) Superposition of 
the BstDnaG-CTD portion of the crystal structure of the BstDnaB-BstDnaG-CTD complex 
(blue) with the NMR structure of (uncomplexed) BstDnaG-CTD (green), showing a 
difference of about 65° between the orientations of their hairpins. (b) Superposition of the 
(uncomplexed) MtDnaG-CTD crystal structure (light blue) with the MtDnaG-CTD portion of 
the model of the complex (orange), showing a difference of about 32° between their hairpin 
orientations. (c) Structure of the BstDnaB/BstDnaG-CTD complex (PDB: 2R6A) used as a 
template for the MtDnaB/MtDnaG model. (d)  Superposition of the structure of MtDnaB-
NTD on that of the BstDnaB-NTD domain, and a superposition of the MtDnaG-CTD GR 
structure on the BstDnaG-CTD GR portion of the structure of the BstDnaB-BstDnaG-CTD 
complex. For superimposing the CTD helical hairpin structures, the helical hairpin of 
MtDnaG-CTD was rotated by about 32°, keeping the linker between the HHR and the GR as 
the center of rotation, in order to obtain the lowest root mean square deviation (RMSD) 
between the BstDnaG-CTD and MtDnaG-CTD structures. 
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Supplementary Table 1: List of primers used for the experiments. 
Fw-MtDnaG-CTD CTAGCTAGCACCCTGTGGCCACAGCGTGAGGCACTC 
Rv-MtDnaG-CTD CGGCTCGAGGTCGCCGCTGGCCTGCTCTAACAGGCT  
Fw-MtDnaGI605A CATGTCGCCGGCGGAGCAAGGCG 
Rv-MtDnaGI605A CGCTGCAGTTTGGACTTC 
Fw-MtDnaGF615A CCACGCGCTGGCGGGCGACCTGG 
Rv-MtDnaGF615A TATTCGTCGCCTTGCTCG 
Fw-MtDnaB-NTD GGAATTCCATATG ATG GGC CGT CAA CCA CCG CAG G 
Rv MtDnaB-NTD CCGCTCGAG CTC TAC CAG CCG GCG CAG CA 
*Primers for DnaG-CTD of H. pylori, E.coli, and V.cholerea were listed previously.  
 
 
Supplementary Table 2: Structure-based alignment of M. tuberculosis DnaG-CTD with 
other structures using Rapido  
Name #aligned 
residues 
RMSD 
rigid 
#aligned residues 
(rigid body) 
RMSD flex #rigid 
bodies 
E. coli 101 12.58 69 0.52 5 
B. stearothermophilus 131 6.82 87 1.01 4 
H. pylori 108 5.24 85 0.90 4 
V. cholerea 122 4.28 77 0.81 3 
 
 
 
 
 
 
 
 
Supplementary Table 3: Average B factors of different regions of the DnaG C-terminal 
domain 
Protein Globular region (Å
2
) Linker (Å
2
) Hairpin helix (Å
2
) 
MtDnaG (PDB) 17.89  25.18  19.28  
EcDnaG (IT3W) 61.70 89.60   66.10  
BstDnaG (2R6A) 98.92  103.06  92.64  
HpDnaG (4EHS) 18.4  24.30  22.70  
VcDnaG (4IM9) 33.87  51.67  39.74  
 
 
Supplementary Table 4: Free binding energy values of the binding of native and mutant 
M. tuberculosis primases to native M. tuberculosis helicase. 
No.  Complex ΔE 
       elec 
(kcal mol
-1
) 
ΔE 
       vdW 
(kcal mol
-1
) 
ΔG 
    polar 
(kcal mol
-1
) 
ΔG 
  nonpolar 
(kcal mol
-1
) 
ΔG 
   binding 
(kcal mol
-
1
) 
1. Native 
MtDnaG-CTD 
-624.8±1.8 -92.3±1.3 960.2±4.0 -20.9±5.6 -100.3±3.7 
2. Mutant 
MtDnaG-CTD 
(I605A) 
-200.0±3.6 -87.8±1.7 906.9±3.8 -3.7±6.6 -60.9±2.4 
3. Mutant 
MtDnaG-CTD 
(F615A) 
-293.2±5.9 -91.9±1.5 913.8±6.82 -14.1±9.0 -75.3±3.2 
 
